CVEvulnerability
CVE-2018-18977
7.5 HIGH
Official page ↗
- Status
- Modified
- Published
- 2019-05-06
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.0 ([email protected])
- 7.5 HIGH — CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- CVSS 2.0 ([email protected])
- 5.0 MEDIUM — AV:N/AC:L/Au:N/C:P/I:N/A:N
- Weaknesses
- CWE-200
Description
An issue was discovered in the Ascensia Contour NEXT ONE application for Android before 2019-01-15. An attacker may reverse engineer the codebase to extract sensitive data that contributes to the disclosure of medical information of patients utilizing the Ascensia platform. This occurs because of weak obfuscation.
Affected configurations
• ascensia contour diabetes (< 2.5.0)
Related
Weakness · CWE (1)
- CWE-200 Exposure of Sensitive Information to an Unauthorized Actor weakness
References
- https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabetic Exploit, Third Party Advisory
- https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabetic Exploit, Third Party Advisory